当今最大的股票变动者:PBI、PHG等
2024-07-29 17:27
Stock futures edged higher in the premarket trading hours of Monday as market participants eagerly awaited earnings reports from the members of the Magnificent 7 due later this week.
Here are some of Monday's biggest stock movers:
Biggest stock gainers
- NewAmsterdam Pharma Company (NASDAQ:NAMS) shares surged over 15% ahead of the scheduled conference call today, where the company will report topline data from its Phase 3 BROOKLYN clinical trial (NCT05425745).
- Koninklijke Philips NV (NYSE:PHG) shares soared over 10% after the Dutch device maker reported better-than-expected Q2 earnings, with comparable sales growth of 2% and a 9% increase in comparable order intake. For FY2024, Philips maintains its forecast of 3-5% comparable sales growth, an adjusted EBITA margin of 11-11.5%, and free cash flow of €0.9B-€1.1B.
- Pitney Bowes (NYSE:PBI) stock climbed 10% after news broke of a potential sale of its e-commerce fulfillment business to logistics startup Stord. Transaction details were not disclosed.
Biggest stock losers
- Abbott's (NYSE:ABT) stock plunged over 5% following a jury verdict ordering the company to pay $495M for allegedly concealing the risks of its premature infant formula.
More on Abbott Laboratories, NewAmsterdam Pharma, etc.
- Abbott Laboratories (ABT) Q2 2024 Earnings Call Transcript
- Abbott Laboratories: When Double-Digit Device Growth Apparently Isn't Enough
- Pitney Bowes: When Less Is More
- Philips Non-GAAP EPS of €0.30, revenue of €4.5B; reaffirms FY24 outlook
- Pitney Bowes sells part of e-commerce business to logistics startup Stord (update)